Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ALK's phase III MITRA trial of new allergy immunotherapy tablet against house dust mite-induced allergic asthma meets primary endpoint
ALK's phase III MITRA trial of new allergy immunotherapy tablet against house dust mite-induced allergic asthma meets primary endpoint
ALK's phase III MITRA trial of new allergy immunotherapy tablet against house dust mite-induced allergic asthma meets primary endpoint
Submitted by
admin
on July 13, 2013 - 12:41pm
Source:
Pharmabiz
News Tags:
asthma
Merck
ALK-Abello
Headline:
ALK's phase III MITRA trial of new allergy immunotherapy tablet against house dust mite-induced allergic asthma meets primary endpoint
Do Not Allow Advertisers to Use My Personal information
